Exploring the Efficacy and Safety of Rivaroxaban to Support Elective Percutaneous Coronary Intervention

Clinical trial NCT01442792 · COMPLETED

Trial details

NCT number: NCT01442792
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cardiovascular Disease Coronary Artery Disease

Start date: 2011-10-12
Primary completion: 2013-01-29
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.